Chemours Co: Form 10-Q for the period ended Jun 30, 2015
Filed with the SEC on Aug 6, 2015 and accepted by EDGAR at Aug 6, 2015, 16:17 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2015-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2015-04-01 to 2015-06-30 | $1.51bn | us-gaap:Revenues |
| Revenue | 6 months2015-01-01 to 2015-06-30 | $2.87bn | us-gaap:Revenues |
| Cost of revenue | 3 months2015-04-01 to 2015-06-30 | $1.28bn | us-gaap:CostOfGoodsSold |
| Cost of revenue | 6 months2015-01-01 to 2015-06-30 | $2.39bn | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months2015-04-01 to 2015-06-30 | $226.0m | us-gaap:GrossProfit |
| Gross profit | 6 months2015-01-01 to 2015-06-30 | $478.0m | us-gaap:GrossProfit |
| Research and development | 3 months2015-04-01 to 2015-06-30 | $27.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2015-01-01 to 2015-06-30 | $50.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2015-04-01 to 2015-06-30 | $157.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2015-01-01 to 2015-06-30 | $324.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 3 months2015-04-01 to 2015-06-30 | $28.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2015-01-01 to 2015-06-30 | $28.0m | us-gaap:InterestExpense |
| Income tax | 3 months2015-04-01 to 2015-06-30 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2015-01-01 to 2015-06-30 | $15.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2015-04-01 to 2015-06-30 | −$18.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2015-01-01 to 2015-06-30 | $25.0m | us-gaap:NetIncomeLoss |
| Operating cash flow | 6 months2015-01-01 to 2015-06-30 | −$233.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2015-01-01 to 2015-06-30 | $287.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2015-06-30 | $247.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2015-06-30 | $2.48bn | us-gaap:AssetsCurrent |
| Total assets | At period end2015-06-30 | $6.68bn | us-gaap:Assets |
| Current liabilities | At period end2015-06-30 | $1.44bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2015-06-30 | $6.28bn | us-gaap:Liabilities |
| Long-term debt | At period end2015-06-30 | $3.93bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2015-06-30 | $16.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2015-06-30 | $401.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001627223-15-000023. Last ingested by Listed: Nov 5, 2026, 19:57 ET. Listed shows no prices and gives no investment advice.